Tissue miR-193b as a Novel Biomarker for Patients with Ovarian Cancer

Abstract

BackgroundMiRNAs play important roles in regulating many fundamental biological processes. Deregulation of miRNAs is involved in the initiation and progression of cancer. MiR-193b is regarded as tumor suppressor in many types of cancers. However, the role of miR-193b in ovarian cancer is poorly understood.Material/MethodsThe expression level of miR-193b in ovarian cancer cell lines and ovarian cancer samples was evaluated using quantitative real-time reverse transcription-PCR (qRT-PCR). The ovarian cancer patients were categorized into a high miR-193b expression group and a low miR-193b expression group according to the median miR-193b expression level. The correlation between tissue miR-193b expression and the patients’ clinicopathological factors, as well as survival, was also analyzed.ResultsThe results showed that the miR-193b expression was significantly down-regulated in ovarian cancer cell lines and tumor tissues compared with normal controls. In addition, tissue miR-193b expression was positively correlated with FIGO stage (P=0.001), histological grade (P=0.032), ascites (P=0.019), lymph node metastasis (P=0.003), and tumor size (P=0.041). Among 116 patients with ovarian cancer examined, the 5-year overall survival (OS) rates were 62.5% and 22.01% in patients with high and low miR-193b expression, respectively (P=0.003). Multivariate analysis showed that tissue miR-193b is an independent prognostic factor in patients with ovarian cancer (HR=4.219; P=0.015).ConclusionsReduction of miR-193b was found in ovarian cancer and its lower expression was associated with poorer prognosis. Tissue miR-193b showed potential as novel biomarker for ovarian cancer.

Potential tumor suppressing role of microRNA-545 in epithelial ovarian cancer

“…Data analysis were performed using the the 2 −ΔΔCq method of normalization (24). U6 was used for the normalization of miR-545 (10,25–27). …”

The tumor suppressor role of miR‑155‑5p in gastric cancer

“…The primers were synthesized by the Sangon Biotech Company (Shanghai, China, http://www.sangon.com/). PCR assay was performed as previously described, with miR-155-5p expression normalized to U6 snRNA expression (14,(21)(22)(23)(24). The primers were: miR-155-5p, forward, 5'-UAA UAC CGU CUU AAA ACC GU-3', and reverse, 5'-UUC UGG GAA CGU GAA ACC T-3'; and U6 snRNA, forward, 5'-CGC TTC GGC AGC ACA TAT ACT AAA ATT GGA AC-3', and reverse, 5'-GCT TCA CGA ATT TGC GTG TCA TCC TTG C-3'.…”

miR‐193: A new weapon against cancer

“…. Collectively, these pieces of evidence clearly suggest a potential role of miR-193a as a proliferation-, invasion-, and metastasis-preventing miRNA in various cancers.Several studies have been emphasized the suppression function of miR-193b in different tumors and tumor cell lines such as breast cancer, glioma, prostate cancer (PC), pancreatic cancer, melanoma, ovarian cancer, and HCCJin et al, 2015;H. Li, Xu, Qiu, Zhao, & Zhang, 2015;Rauhala et al, 2010;C.…”